DailyDoctor Archive Specialties Get app
Back to the 19 September 2026 edition

Research · 04 of 06

A third of children with neurofibromatosis type 1 have ADHD

Make ADHD screening and a school-progress question routine parts of neurofibromatosis type 1 follow-up.

Design
systematic review and random-effects meta-analysis of prevalence studies to April 2026
Population
50 studies of children and adults with neurofibromatosis type 1, with genotype separated where possible
Primary outcome
prevalence of intellectual disability, autism, ADHD, seizures and emotional disorders
Effect
ADHD 33% (95% CI 26–40); autism 11% (7–14); intellectual disability 8% (6–11); seizures 11% (8–14)

Fifty studies were pooled to estimate how often neuropsychiatric and seizure disorders occur in neurofibromatosis type 1, a condition usually followed for its tumours and its skin.

Attention deficit hyperactivity disorder was present in 33% (95% CI 26 to 40, from 29 studies) — by some distance the commonest finding. Autism spectrum disorder was present in 11% (7 to 14), intellectual disability in 8% (6 to 11), seizures in 11% (8 to 14) and epilepsy in 9% (6 to 11). Depression affected 13% (3 to 23) and anxiety 12% (5 to 20). Where genotype could be separated, children with NF1 microdeletions fared considerably worse: intellectual disability 41% (29 to 52) and ADHD 45% (25 to 65), though each of those rests on only two studies.

These are prevalence estimates from heterogeneous cohorts, many of them drawn from specialist clinics, which tends to overstate severity. Even allowing for that, a one-in-three ADHD figure changes what a routine NF1 review should cover. The neurodevelopmental burden is the part of this condition most likely to determine how a child does at school, and it is the part least likely to come up in a clinic organised around measuring café-au-lait spots and checking for plexiform neurofibromas.

  • Include a neurodevelopmental and school-progress question in every NF1 review
  • Screen for ADHD specifically rather than waiting for the school to raise it
  • Ask about mood and anxiety in older children and adolescents with NF1
  • Where a microdeletion genotype is known, expect higher neurodevelopmental burden and plan assessment accordingly

Why it matters

The part of NF1 most likely to shape a child's schooling is the part a tumour-focused review does not ask about.

Don't overread it

Pooled prevalence from specialist cohorts tends to overstate how common these problems are in the whole NF1 population.

The statistics, in plain English

Pooled prevalence figures carry wide intervals here because the underlying cohorts differ in how they ascertained cases — 3% to 23% for depression is close to uninformative about any individual clinic. The microdeletion estimates rest on two studies each and should be read as a signal that this genotype is worse, not as a number. Specialist-clinic cohorts systematically overrepresent severe disease, so these are probably upper bounds for a general population.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

neonataladolescentimmunisationneurodevpaedemergency

Tomorrow morning, before your first patient

One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app